Personalizing Prostate Cancer Care With Genetic Testing, PARP Inhibitors
Dr. Kristen Scarpato explains the role of genetic testing in prostate cancer care, as well as its use in determining treatment with PARP inhibitors.
Immune Therapy Expands Melanoma Treatment to More Patients
Immune therapy is generally safer than chemotherapy, allowing more patients with melanoma and other conditions like heart or lung issues receive treatment.
Reassessing Immunotherapy Use in Advanced Renal Cell Carcinoma
There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were treated in the advanced setting.
ctDNA Testing May Offer Patients With RCC ‘Peace of Mind’
Dr. Alan Tan explores circulating tumor DNA, its role in clinical trials and its potential impact on patients with renal cell carcinoma.
Circulating Tumor DNA May Have Prognostic Value in Kidney Cancer
Dr. Alan Tan spoke with CURE® about what patients with kidney cancer and providers who treat it may be able to learn from ctDNA.
